Delisting risk
TNON · NASDAQ · Medical - Devices

Tenon Medical

SI-joint fusion implants delivered through complementary minimally invasive surgical approaches.

$5.00
After-hours close+0.03 (+0.50%)
At close$4.98(−0.90%)

Breakdown13F · Form 4

Institutions Insiders 10.72%

Shares outstanding 496.5K · Float 445.3K · 89.7% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Armistice Capital, LLC54.6K9.99%13GAug 14, 2026

Institutions13F

No 13F holders on record.

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
SiVantage Inc.12.50%13DAug 8, 2025
Armistice Capital, LLC9.99%54.6K13GAug 14, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Wyatt D. Geistofficer: Chief Innovation Officer18.4K3.71%May 5, 2026
Nathaniel A. Graweyofficer: Chief Commercial Officer13.8K2.78%May 5, 2026
Steven M. Fosterdirector, officer: CEO and President7.5K1.51%Aug 4, 2026
Richard Ginndirector, officer: Chief Technology Officer4.8K0.96%Aug 4, 2026
Richard Ferraridirector3.9K0.79%Aug 4, 2026
Kevin Williamsonofficer: Chief Financial Officer2.6K0.52%Aug 4, 2026
Kristine M. Jacquesdirector5960.12%Aug 4, 2026
Ivan Howarddirector5720.12%Aug 4, 2026
Stephen Hochschulerdirector5400.11%Aug 4, 2026
Robert K. Weigledirector5220.11%Aug 4, 2026

1 ten-percent owner holds 874 shares by Form 4, outside the officers-and-directors figure above · 2 people have not refiled in the last 18 months (38 shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Nov 14, 2025
Nathaniel A. Graweyofficer: Chief Commercial Officer
Purchase · 2 lots202,334$1.16340,448
Nov 14, 2025
Wyatt D. Geistofficer: Chief Innovation Officer
Purchase · 2 lots38,910$1.16177,024
Nov 14, 2025
Steven M. Fosterdirector, officer: CEO and President
Purchase · 2 lots38,910$1.1642,333

CongressHouse and Senate disclosures

Not reported.